Where does Synergia Medical rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Synergia Medical ranks #20,482 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Synergia Medical hold?

Synergia Medical holds 14 US utility patents granted between 2019 and 2025, spanning 8 technology areas.

What is Synergia Medical's Innovation Score?

Synergia Medical has an Innovation Score of 42.0 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Synergia Medical focus on?

Synergia Medical's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 14 patents, ranking #259 of 1,943 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Synergia Medical's patent grant rate increasing or decreasing?

Synergia Medical's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Synergia Medical's patents?

Synergia Medical's patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Synergia Medical patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Synergia Medical

USPTO PatentsView assignee record - 14 granted patents across 8 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Synergia ranks #20,482 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 8 technology areas.

#20,482
of 49,997 US assignees by volume: Top 32%
by Innovation Score (42.0/100): 15.5
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20482 · Foreign Corporation #20,482 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,482/49,997
PHOTO-FINISH Surefire Medical
CPC-NARROW A61N · 8 areas
INNOV-PAR 42.0/100
CLAIMS-RICH 15.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Surefire Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Synergia’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (22%) Velocity 13.3 pts (32%) Breadth 10.0 pts (24%) Claim depth 9.3 pts (22%)

Qualcomm Incorporated · highest

85
Synergia Medical · this assignee

42
3D Lighting… · lowest

7

What this shows Synergia's Innovation Score is 42.0/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Synergia?

Each dot is one of Synergia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Synergia’s own 15.5 claims/patent is at or below the 18.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Synergia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Synergia's grants concentrate

Synergia Medical is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (5 grants) versus a trough of 2 in 2019. By volume, Synergia sits between SureHarvest, Inc. and T&M Inventions, LLC.

Synergia's three-year grant acceleration

Synergia Medical shows 8 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sureharvest

14
Surefire Medical

14
Surface Tech

14
Suzano

14
Synthego

14
Syntheon

14
Sytheon

14
T&M Inventions

14
Synergia Medical ◀

14

What this shows Synergia holds 14 patents at rank #20,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Synergia

By rank, the assignees closest to #20,478 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Synergia's primary technology class.

Synergia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Synergia Medical patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	14.3%
2021	2	14.3%
2022	3	21.4%
2024	5	35.7%
2025partial year	2	14.3%

Which technologies does Synergia Medical patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 14

A61B - DIAGNOSIS; SURGERY; Identification 7

G02B - Optical Elements, Systems OR Apparatus 3

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

H02S - Generation OF Electric Power BY Conversion OF Infrared Radiation, Visible Light OR Ultraviolet Light, e.g. Using Photovoltaic [PV] Modules 1

C08L - Compositions OF Macromolecular Compounds 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Synergia Medical's patent record in context - here's where to go next.

Synergia Medical's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #20,482 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Synergia Medical against SureHarvest, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.